NEW YORK, Aug. 9, 2016 /PRNewswire/ -- Attorney
Advertising -- Bronstein, Gewirtz & Grossman, LLC is
investigating potential claims on behalf of purchasers of the
securities of Albany Molecular Research, Inc. ("Amri" or
the "Company") (NASDAQ: AMRI). Such investors are advised to
contact Peretz Bronstein or his
investor relations analyst, Yael
Hurwitz at info@bgandg.com or 212-697-6484.
The investigation concerns whether Amri and certain of its
officers and/or directors have violated Sections 10(b) of the
Securities Exchange Act of 1934 and have breached their fiduciary
duties to the Company and its shareholders by failing to implement
adequate internal controls over its management and disclosure
procedures.
Amri is a contract research and manufacturing organization that
provides drug discovery, development, cGMP manufacturing and
aseptic fill and finish to the pharmaceutical and biotechnology
industries.
Amri has allegedly been hiding from its investors information
about a weather-related power outage at its New Mexico laboratory in July 2014 that spoiled its inventory.
Particularly, Amri's Chief Executive Officer apparently knew about
the power outage and this laboratory's importance to core
operations and nevertheless failed to inform shareholders. Truth of
this power outage was not released until November 5, 2014, when Amri announced the need to
temporarily close the facility and dispose of the reuined
inventory. Following this news, Amri stock dropped $6.08 per share, or 35%, to close at $16.59 per share on November 5, 2014.
If you purchased Amri shares or if you are aware of any facts
relating to this investigation, you can assist this investigation
by visiting the firm's site: http://www.bgandg.com/amri. You can
also contact Peretz Bronstein or his
Investor Relations Analyst, Yael
Hurwitz of Bronstein, Gewirtz & Grossman, LLC:
212-697-6484 or via email info@bgandg.com. Those who inquire
by e-mail are encouraged to include their mailing address, email
and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/shareholder-alert-bronstein-gewirtz--grossman-llc-announces-investigation-of-albany-molecular-research-inc-amri-300310753.html
SOURCE Bronstein, Gewirtz & Grossman, LLC